Search research articles
Contact Us
Filters
Showing results (61-70 of 187) with videos related to
Page
of 19
Sort By:
British Journal of Haematology
|
April 18, 2013
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
Yasuhiro Oki, Anas Younes, Amanda Copeland, et al.
The Journal of Investigative Dermatology
|
May 7, 2026
Cutaneous B-Cell Lymphoma Incidence Trends in the United States: A Surveillance, Epidemiology, and End Results Analysis of 10,975 Cases
Joshua A Kent, Yoni Sacknovitz, Samuel A Fisch, et al.
JAMA Network Open
|
March 12, 2020
Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs
Mudit Chowdhary, Akansha Chowdhary, Trevor J Royce, et al.
Cancer
|
June 18, 2011
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, et al.
Cancer
|
March 17, 2004
Thalidomide for patients with recurrent lymphoma
Barbara Pro, Anas Younes, Maher Albitar, et al.
Leukemia & Lymphoma
|
September 14, 2020
Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma
Felipe Samaniego, Peter McLaughlin, Sattva S Neelapu, et al.
The Journal of Investigative Dermatology
|
April 10, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls
Yoni Sacknovitz, Maggie H Zhou, Joshua Kent, et al.
Leukemia & Lymphoma
|
April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas
Hoon K Lee, Richard B Wilder, Dan Jones, et al.
Cancer
|
November 30, 2006
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma
Yasuhiro Oki, Peter McLaughlin, Luis E Fayad, et al.
British Journal of Haematology
|
April 27, 2011
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma
Michelle Fanale, Luis Fayad, Barbara Pro, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 187) with videos related to
Sort By:
Page
of 19
British Journal of Haematology
|
April 18, 2013
Phase I study of vorinostat in combination with standard CHOP in patients with newly diagnosed peripheral T-cell lymphoma
Yasuhiro Oki, Anas Younes, Amanda Copeland, et al.
The Journal of Investigative Dermatology
|
May 7, 2026
Cutaneous B-Cell Lymphoma Incidence Trends in the United States: A Surveillance, Epidemiology, and End Results Analysis of 10,975 Cases
Joshua A Kent, Yoni Sacknovitz, Samuel A Fisch, et al.
JAMA Network Open
|
March 12, 2020
Women's Representation in Leadership Positions in Academic Medical Oncology, Radiation Oncology, and Surgical Oncology Programs
Mudit Chowdhary, Akansha Chowdhary, Trevor J Royce, et al.
Cancer
|
June 18, 2011
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, et al.
Cancer
|
March 17, 2004
Thalidomide for patients with recurrent lymphoma
Barbara Pro, Anas Younes, Maher Albitar, et al.
Leukemia & Lymphoma
|
September 14, 2020
Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma
Felipe Samaniego, Peter McLaughlin, Sattva S Neelapu, et al.
The Journal of Investigative Dermatology
|
April 10, 2026
Serum proteomics analysis identifies differentially expressed proteins in early-stage mycosis fungoides versus healthy controls
Yoni Sacknovitz, Maggie H Zhou, Joshua Kent, et al.
Leukemia & Lymphoma
|
April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas
Hoon K Lee, Richard B Wilder, Dan Jones, et al.
Cancer
|
November 30, 2006
Experience with heat shock protein-peptide complex 96 vaccine therapy in patients with indolent non-Hodgkin lymphoma
Yasuhiro Oki, Peter McLaughlin, Luis E Fayad, et al.
British Journal of Haematology
|
April 27, 2011
Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma
Michelle Fanale, Luis Fayad, Barbara Pro, et al.
Page
of 19